Hot and Cold Compress in Hemodialysis

NCT04681521 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2020-12-23

No results posted yet for this study

Summary

Aims and objectives. To examine and compare the effects of hot and cold compresses administration on muscle cramps, fatigue, and comfort in hemodialysis (HD) patients.

Background. Muscle cramps and fatigue are common complications in HD patients and reduce patient comfort. Among the nursing interventions stated for the management of these complications in the literature, hot and cold therapy are remarkable. To the best of our knowledge, the present study is the first research up to date that examined and compared the effects of hot and cold compress administrations on abovementioned complications in HD.

Design. This placebo-controlled randomized trial was conducted in two hemodialysis centers between February and October 2020.

Methods. The study sample consisted of 69 patients, stratified and randomly allocated to two intervention groups and placebo group. For patients of each group, the implementation of the study continued for four weeks, 12 HD sessions.

Conditions

  • Hemodialysis Complication
  • Muscle Spasm
  • Fatigue

Interventions

OTHER

Hot and Cold compress, nursing interventions

using thermal compress at 38-39 °C (hot) and 15-16 °C (cold) on the distal regions of both lower extremities of the patients

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Leyla Özdemir, Prof. Dr. · Hacettepe University

  • Tolga Yıldırım, Assos. Prof. · Hacettepe University

  • Cebrail Cebrailov, M.D. · Hacettepe University

  • Gülseren Çeliksöz, M.D. · Betamar Dialysis Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2020-10-30
Completion
2020-11-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04681521 on ClinicalTrials.gov